查詢結果分析
相關文獻
頁籤選單縮合
題 名 | Both Gefitinib and Erlotinib Induced Drug-related Interstitial Lung Disease in a Patient with Pulmonary Adenocarcinoma |
---|---|
作 者 | Wang, Ko-fan; Chang, Cheng-yu; Chang, Shih-chieh; Liu, Yu-chang; Yuan, Mei-kang; Yang, Yuan-hao; | 書刊名 | Journal of the Chinese Medical Association |
卷 期 | 76:3 2013.03[民102.03] |
頁 次 | 頁173-175 |
分類號 | 415.46 |
關鍵詞 | Erlotinib; Gefitinib; Interstitial lung disease; |
語 文 | 英文(English) |
英文摘要 | Treatment for non-small-cell lung cancer with gefitinib and erlotinib is efficacious. However, while many studies have reported on gefitinibrelated interstitial lung disease (ILD), less published data are available regarding erlotinib-induced ILD. Here, we report a case of pulmonary adenocarcinoma who developed ILD due to gefitinib initially and erlotinib thereafter. The two episodes of ILD were treated successfully with the discontinuation of the tyrosine kinase inhibitors and high-dose intravenous corticosteroids. |
本系統中英文摘要資訊取自各篇刊載內容。